HighTower Advisors
GNPX icon

HighTower Advisors’s Genprex GNPX Stock Holding History

HighTower Advisors’s Portfolio GNPX Stock Details GNPX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-13
Closed -$3.19K – 3929
2025
Q2 		$3.19K Sell
13
-59
-82% -$18K ﹤0.01% 3700
2025
Q1 		$19.5K Buy
72
+59
+454% +$32.8K ﹤0.01% 3521
2024
Q4 		$11.8K Sell
13
-6
-32% -$7.86K ﹤0.01% 3577
2024
Q3 		$8K Buy
+19
New +$23.5K ﹤0.01% 3568
2023
Q3 		– Hold
0
– -$12K – 3644
2023
Q2 		– Hold
0
– – – 3291
2022
Q3 		– Sell
-1
Closed -$44K – 3243
2022
Q2 		$44K Buy
+1
New +$70.4K ﹤0.01% 2917
2022
Q1 		– Hold
0
– – – 3144
2021
Q4 		– Sell
-1
Closed -$70K – 3370
2021
Q3 		$70K Buy
+1
New +$129K ﹤0.01% 2897
2020
Q4 		– Hold
0
– -$12K – 2705
2020
Q3 		– Hold
0
– – – 2411
2020
Q2 		– Hold
0
– – – 2265
2020
Q1 		– Hold
0
– – – 2111

Other funds holding GNPX

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
Jane Street
Jane Street New York $777B AUM 61.18% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
HIP
HUB Investment Partners Austin, Texas $4.18B AUM 24.76% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return
Citigroup
Citigroup New York $235B AUM 32.99% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return

HighTower Advisors's GNPX Position: Q3 2025 in Review

HighTower Advisors sold out of Genprex (GNPX) in Q3 2025, closing a stake of 13 shares — an estimated $3.19K sold.

HighTower Advisors first reported a position in GNPX in Q3 2021 and held it in 6 quarters. The position peaked at $70K in Q3 2021. 13 funds tracked by Wall St. Rank hold GNPX as of Q3 2025.

  • HighTower Advisors reported no remaining Genprex position as of Q3 2025 after selling out during the quarter.
  • HighTower Advisors sold 13 Genprex shares in Q3 2025, an estimated $3.19K.
  • HighTower Advisors first reported a position in Genprex in Q3 2021 and held it in 6 quarters.
  • HighTower Advisors's Genprex position peaked at $70K in Q3 2021.
  • 13 funds tracked by Wall St. Rank held Genprex as of Q3 2025.

Based on HighTower Advisors's 13F filing for Q3 2025, filed 7 Nov 2025.